| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $34.50M | - | |
| CEO | 411.2K | $32.85M | - | |
| VP | 158.5K | $12.66M | - | |
| Other | 91.3K | $7.29M | - | |
| VP | 84.0K | $6.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Rowland Thomas Andrew | SVP, Head - Established Brands | Sell | 4,975 | $85.71 | $426,407.25 | -10.9% | +0.7% | - | |
| Aug 12, 2025 | Haughey Thomas | Director | Sell | 19,341 | $85.93 | $1,661,972.13 | -34.6% | +0.7% | - | |
| Jul 14, 2025 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 400 | $64.88 | $25,952.00 | -0.5% | +35.9% | +23.6% | |
| Jun 13, 2025 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 400 | $61.37 | $24,548.00 | -0.5% | +57.8% | +30.6% | |
| May 15, 2025 | Gutwerg Ori47 | SVP, Generics | Sell | 881 | $60.07 | $52,921.67 | -1.0% | +49.1% | +31.0% | |
| May 14, 2025 | Mutz Christopher | Head Of Rare Disease | Sell | 4,000 | $60.45 | $241,800.00 | -3.6% | +46.3% | +31.8% | |
| May 13, 2025 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 400 | $62.20 | $24,880.00 | -0.5% | +36.9% | +30.5% | |
| May 9, 2025 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 700 | $76.83 | $53,781.00 | -0.1% | +4.1% | +23.5% | |
| Apr 14, 2025 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 400 | $68.96 | $27,584.00 | -0.5% | -5.1% | +14.0% | |
| Mar 19, 2025 | Davis Krista45 | SVP, Chief Hr Officer | Sell | 1,866 | $65.00 | $121,290.00 | -2.8% | -2.3% | +15.3% |